Results 211 to 220 of about 129,195 (289)

Primary Cardiac Lymphoma: A Diagnostically Challenging Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT This case highlights the diagnostic difficulties of PCL, including non‐specific symptoms, imaging mimics, and the critical role of histopathological confirmation despite technical and clinical challenges. Early multidisciplinary evaluation is essential to improve outcomes in this aggressive disease.
Yucheng Huang, Minxi Lao, Min Ye, Yang Yang, Meilin Ding, Jin Li, Lei Su   +6 more
wiley   +1 more source

Acute Gout Flare After Carboplatin/5-Fluorouracil for Locally Advanced Head and Neck Squamous Cell Carcinoma. [PDF]

Cancer Rep (Hoboken)
Zou H, Janadi AA, Sako Z.
europepmc   +1 more source

Lessons From Two Cases of Life‐Threatening Hemorrhage Which Occurred Immediately Before Tooth Extraction in Elderly Cancer Patients With Diabetes

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Tooth extraction is often required before chemoradiotherapy in patients with cancer. We herein report two cases of elderly cancer patients who experienced life‐threatening hemorrhage immediately before scheduled extractions. Case 1 involved a 79‐year‐old man who underwent chemotherapy for malignant lymphoma.
Sumitaka Hagiwara, Reika Hasegawa, Shigeru Kusumoto, Shintaro Beppu, Nobuhiro Hanai   +4 more
wiley   +1 more source

A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy. [PDF]

Support Care Cancer
Harikul W, Nimmannit A, Laocharoenkeat A, Phisalprapa P, Kositamongkol C, Thongkijpreecha P, Ithimakin S.   +6 more
europepmc   +1 more source

Paraneoplastic Lupus Nephritis in a Child With Neuroblastoma Recurrence

Pediatric Blood &Cancer, Volume 73, Issue 5, May 2026.
Gabriele Mortari, Caterina Costagliola, Marta Nebiolo, Francesca Parisi, Martina Morini, Katia Mazzocco, Gabriele Gaggero, Stefano Volpi, Stefania Sorrentino, Virginia Livellara   +9 more
wiley   +1 more source

Genetic and Immunohistochemical Profiling of Malignant Mesothelioma With Brain Metastasis: A Report of Two Cases

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Brain metastasis (BM) occurs in < 3% of malignant mesothelioma (MM) cases and is associated with an aggressive disease course. While genomic profiling has provided insight into molecular alterations in MM, the characteristics of MM with brain involvement remain unexplored.
Paul M. Harary, Yusuke S. Hori, Ruchit Jain, Ahed H. Kattaa, Melanie Hayden Gephart, Michael F. Gensheimer, Scott G. Soltys, David J. Park, Steven D. Chang   +8 more
wiley   +1 more source

Serum Symmetric Dimethylarginine as a Predictor of Toxicity of Carboplatin in Dogs. [PDF]

Vet Comp Oncol
Gareau A, Papich MG, Evans BJ, Intile JL.   +3 more
europepmc   +1 more source

Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer

Immunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Background The convergence of nanotechnology and immunotherapy has ushered in a transformative era in cancer treatment, offering new strategies to overcome pharmacokinetic limitations and immune evasion associated with conventional therapies. While immunotherapy, spanning checkpoint inhibitors, adoptive cell transfer, and cancer vaccines, has ...
Nima Javanmehr, Asal Moazzami Ashtyani, Robabehbeygom Ghafelehbashi, Fateme Mousavi, Hossein Teimouri   +4 more
wiley   +1 more source

Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report. [PDF]

Cureus
Maistrenko Y, Manzhura O, Kravchuk O.
europepmc   +1 more source

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

International Journal of Cancer, Volume 158, Issue 9, Page 2429-2439, 1 May 2026.
What's new? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu, Li Zhang, Yun Fan, JianYing Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, GongYan Chen, Xin Zhang, CaiCun Zhou, Carmen González Arenas, Zhenghong Chen, Wen Cheng Yu, Tony S. K. Mok   +14 more
wiley   +1 more source